Gilead Sciences shares surged Thursday following reports detailing encouraging partial data from trials of the U.S. company’s experimental drug remdesivir in COVID-19 patients. A University of Chicago hospital participating in a study on the drug said it is seeing rapid recoveries in fever and respiratory symptoms. Gilead said ’the totality of the data need to be analyzed’.
Gilead? As in The Handmaid’s Tale?
One of the best companies In pharma with some of greatest minds for producing quality anti protease inhibitors n other pharmakinectics.. Thank u